Universal Beteiligungs und Servicegesellschaft mbH reduced its stake in shares of Teleflex Incorporated (NYSE:TFX – Free Report) by 17.1% in the second quarter, according to its most recent filing with the SEC. The institutional investor owned 9,216 shares of the medical technology company’s stock after selling 1,902 shares during the period. Universal Beteiligungs und Servicegesellschaft mbH’s holdings in Teleflex were worth $1,091,000 as of its most recent filing with the SEC.
Several other institutional investors and hedge funds have also recently modified their holdings of TFX. Cetera Investment Advisers purchased a new position in shares of Teleflex during the first quarter valued at approximately $206,000. Empirical Finance LLC lifted its stake in Teleflex by 7.9% during the 1st quarter. Empirical Finance LLC now owns 1,690 shares of the medical technology company’s stock valued at $234,000 after acquiring an additional 124 shares in the last quarter. LPL Financial LLC boosted its holdings in Teleflex by 15.6% during the 1st quarter. LPL Financial LLC now owns 40,365 shares of the medical technology company’s stock worth $5,578,000 after acquiring an additional 5,434 shares during the last quarter. Mackenzie Financial Corp grew its stake in shares of Teleflex by 45.1% in the 1st quarter. Mackenzie Financial Corp now owns 52,651 shares of the medical technology company’s stock worth $7,276,000 after acquiring an additional 16,370 shares in the last quarter. Finally, Banque Cantonale Vaudoise purchased a new stake in shares of Teleflex in the first quarter valued at about $27,000. 95.62% of the stock is owned by hedge funds and other institutional investors.
Analyst Upgrades and Downgrades
Several research analysts recently weighed in on the stock. Wells Fargo & Company cut their price target on shares of Teleflex from $131.00 to $114.00 and set an “equal weight” rating on the stock in a report on Friday, November 7th. Royal Bank Of Canada dropped their target price on shares of Teleflex from $135.00 to $120.00 and set a “sector perform” rating on the stock in a research report on Friday, November 7th. Mizuho boosted their target price on Teleflex from $130.00 to $135.00 and gave the stock a “neutral” rating in a research note on Friday, August 1st. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Teleflex in a research report on Tuesday. Finally, Wall Street Zen lowered Teleflex from a “buy” rating to a “hold” rating in a report on Saturday, November 15th. One research analyst has rated the stock with a Buy rating, nine have assigned a Hold rating and two have issued a Sell rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Reduce” and a consensus target price of $134.57.
Teleflex Price Performance
Teleflex stock opened at $115.60 on Thursday. The business’s 50 day simple moving average is $120.69 and its 200 day simple moving average is $121.24. Teleflex Incorporated has a 12 month low of $102.58 and a 12 month high of $195.24. The company has a market cap of $5.11 billion, a price-to-earnings ratio of 27.20, a PEG ratio of 1.79 and a beta of 1.05. The company has a current ratio of 2.41, a quick ratio of 1.44 and a debt-to-equity ratio of 0.42.
Teleflex (NYSE:TFX – Get Free Report) last issued its earnings results on Thursday, November 6th. The medical technology company reported $3.67 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.38 by $0.29. The firm had revenue of $892.90 million for the quarter, compared to analyst estimates of $892.79 million. Teleflex had a return on equity of 15.08% and a net margin of 6.31%.The business’s revenue was up 19.4% on a year-over-year basis. During the same period in the previous year, the company posted $3.49 earnings per share. Teleflex has set its FY 2025 guidance at 14.000-14.200 EPS. Sell-side analysts forecast that Teleflex Incorporated will post 13.98 EPS for the current year.
Teleflex Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Monday, December 15th. Shareholders of record on Friday, November 14th will be issued a dividend of $0.34 per share. The ex-dividend date of this dividend is Friday, November 14th. This represents a $1.36 annualized dividend and a yield of 1.2%. Teleflex’s dividend payout ratio is -18.50%.
Teleflex Profile
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.
Further Reading
- Five stocks we like better than Teleflex
- What is a Special Dividend?
- Tesla Just Got Called a “Must Own” Stock—Here’s Why
- Conference Calls and Individual Investors
- Why Gold Loves Trump as Much as Trump Loves Gold
- What is a penny stock? A comprehensive guide
- Google’s Gemini 3 Sends Broadcom Soaring: TPUs Take Center Stage
Receive News & Ratings for Teleflex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex and related companies with MarketBeat.com's FREE daily email newsletter.
